FIELD: medicine, pharmaceutics.
SUBSTANCE: invention refers to medicine, namely to pharmaceutical compositions for treating urination disturbance that is a syndrome manifested by frequent urination, urinary incontinence, urine retention, etc. The pharmaceutical composition contains an anticholinergic preparation that is diphenyl-acetic acid tropine ester, and preparations of the other mode of action, including Tamsulosin hydrochloride or calcium channels or baclofen in the form of prolonged release tablets or capsules or transdermal dosage forms (gels, ointments or plasters).
EFFECT: using the invention enables extending the range of therapeutic agents and improving the clinical effectiveness in urination disturbances accompanying a variety of common urological, neurological and gynaecological conditions alongside with improving the quality of life in patients with the urination disturbance.
4 cl, 24 tbl, 3 ex
| Title | Year | Author | Number |
|---|---|---|---|
| AGENT REDUCING INTENSITY OF DETRUSOR WITH IMPAIRED CONTRACTILITY | 2016 |
|
RU2714444C2 |
| METHOD FOR TREATING NEUROGENIC URINARY BLADDER DYSFUNCTION CASES | 2004 |
|
RU2295364C2 |
| PHENOXYACETIC ACID DERIVATIVES APPLICATION IN TREATMENT FOR HYPERACTIVITY OF URINARY BLADDER | 2004 |
|
RU2342133C2 |
| METHOD FOR INCREASING TUBERCULOUS SPASTIC BLADDER CAPACITY | 2007 |
|
RU2401080C2 |
| PEPTIDE PHARMACEUTICAL COMPOSITION NORMALISING URINATION, AND METHOD OF APPLICATION THEREOF | 2007 |
|
RU2367467C2 |
| PHARMACEUTICAL COMBINATION CONTAINING VINPOCETINE AND BETAHISTINE FOR TREATING CEREBRAL CIRCULATORY DEPRESSION | 2008 |
|
RU2386439C2 |
| USE OF 6-DIMETHYLAMINOMETHYL-1-PHENYLCYCLOHEXANE COMPOUNDS IN ENURESIS THERAPY | 2001 |
|
RU2280444C2 |
| USING SUBSTITUTED 6-DIMETHYLAMINOMETHYL-1-PHENYLHEXANE COMPOUNDS IN ENURESIS THERAPY | 2001 |
|
RU2279875C2 |
| METHOD OF REDUCING FREQUENCY OF URGENCY INCONTINENCE IN WOMEN | 2009 |
|
RU2404827C1 |
| METHOD OF TREATMENT OF CHILDREN AGED 5 TO 17 YEARS WITH NEUROGENIC DETRUSOR HYPERACTIVITY IN COMBINATION WITH MYELODYSPLASIA AND VASCULAR HYPOTENSION | 2022 |
|
RU2799477C1 |
